Showing results (131-140 of 140) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Blood|February 14, 2018
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trialAnne-Ségolène Cottereau, Annibale Versari, Annika Loft, et al.Cell Reports. Medicine|November 10, 2021
Altered brown fat thermoregulation and enhanced cold-induced thermogenesis in young, healthy, winter-swimming menSusanna Søberg, Johan Löfgren, Frederik E Philipsen, et al.Gynecologic Oncology|December 4, 2012
MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative studySofie Leisby Antonsen, Lisa Neerup Jensen, Annika Loft, et al.The New England Journal of Medicine|July 3, 2009
Preoperative staging of lung cancer with combined PET-CTBarbara Fischer, Ulrik Lassen, Jann Mortensen, et al.Leukemia & Lymphoma|October 21, 2014
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup studyKaren Juul Mylam, Lale Kostakoglu, Martin Hutchings, et al.Haematologica|March 25, 2014
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleAndrea Gallamini, Sally F Barrington, Alberto Biggi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical ImplementationRonald Boellaard, Irène Buvat, Christophe Nioche, et al.The Lancet. Haematology|May 2, 2026
Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.Blood|March 22, 2014
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphomaArne Kolstad, Anna Laurell, Mats Jerkeman, et al.Pageof 14